Dudediligence.

Alto Neuroscience, Inc

ANRONYSE · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$16.8MSep ’24−$15.2MDec ’24−$15.2MMar ’25−$17.7MJun ’25−$14.2MSep ’25−$16.2MDec ’25−$26.2MMar ’26−$27.6MJun ’26
Fiscal years, by the month each ended
LineDec 2022Dec 2023Dec 2024Dec 2025
Operating incomenone on file−$37.8M−$68.6M−$66.4M
Net incomenone on file−$36.3M−$61.4M−$63.2M
Operating cash flownone on file−$33.4M−$47.4M−$51.8M
Free cash flownone on file−$33.9M−$49.5M−$51.8M
Cash$48.3M$82.5M$168.2M$176.5M
Debtnone on file$9.9M$10.3M$16.8M
Shares outstandingnone on file3.8M27.0M31.9M